SRTS Stock Sensus Healthcare (SRTS, $3.38) Stochastic Oscillator left the overbought zone on September 02, 2025

GET DAILY SIGNALS

Get AI intraday signals

SRTS - Sensus Healthcare

Stochastic signal

View

Odds of DOWN Trend

Price: $3.38

Daily change: -$0.01 (-0.29%)

Daily volume: 83.8K

Capitalization: $55.6M

Industry: Medical/Nursing Services

SRTS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for SRTS turned positive on August 29, 2025. Looking at past instances where SRTS's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SRTS's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 29, 2025. You may want to consider a long position or call options on SRTS as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTS advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

SRTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

SRTS moved below its 50-day moving average on August 08, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SRTS crossed bearishly below the 50-day moving average on August 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.026) is normal, around the industry mean (60.022). P/E Ratio (31.500) is within average values for comparable stocks, (37.782). SRTS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.667). SRTS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (1.416) is also within normal values, averaging (80.699).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SRTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.